CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 56 filers reported holding CABALETTA BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,594,000 | +6.6% | 104,763 | -9.5% | 0.00% | – |
Q2 2023 | $1,495,000 | +78.8% | 115,805 | +14.5% | 0.00% | – |
Q1 2023 | $836,000 | +41700.0% | 101,098 | +41333.6% | 0.00% | – |
Q4 2022 | $2,000 | – | 244 | -36.5% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 384 | -74.0% | 0.00% | – |
Q2 2021 | $13,000 | -13.3% | 1,476 | +8.8% | 0.00% | – |
Q1 2021 | $15,000 | +66.7% | 1,356 | +96.2% | 0.00% | – |
Q4 2020 | $9,000 | – | 691 | +6810.0% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 10 | -96.8% | 0.00% | – |
Q1 2020 | $2,000 | -66.7% | 313 | -22.3% | 0.00% | – |
Q4 2019 | $6,000 | – | 403 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 2,064,263 | $4,190,000 | 0.92% |
Kynam Capital Management, LP | 616,125 | $1,251,000 | 0.41% |
Ikarian Capital, LLC | 1,020,070 | $2,070,000 | 0.27% |
Cormorant Asset Management, LP | 1,154,424 | $2,343,000 | 0.18% |
Ikarian Capital, LLC | 449,000 | $912,000 | 0.12% |
HARBOR CAPITAL ADVISORS, INC. | 119,315 | $242,000 | 0.11% |
Boxer Capital, LLC | 540,000 | $1,096,000 | 0.06% |
SAMLYN CAPITAL, LLC | 1,768,083 | $3,589,000 | 0.05% |
Redmile Group, LLC | 696,377 | $1,414,000 | 0.04% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 464,252 | $942,000 | 0.02% |